Story perspectives

J.P. Morgan Healthcare Conference: M&A Buzz Amid Quiet Deals

1/15/2026

36 5

Summary

Story summary

The J.P. Morgan Healthcare Conference did not yield a billion-dollar deal or major announcements.
Attendees noted a shift toward pre-conference disclosures, with many firms announcing developments beforehand.
The absence of major payers after a 2024 tragedy shifted focus to biopharma.
Merck and Revolution Medicines are reportedly in talks for significant acquisitions, signaling rising M&A activity.
The conference remained busy with side events despite the lack of blockbuster announcements.

1 of 1

Story summary

The J.P. Morgan Healthcare Conference did not yield a billion-dollar deal or major announcements.
Attendees noted a shift toward pre-conference disclosures, with many firms announcing developments beforehand.
The absence of major payers after a 2024 tragedy shifted focus to biopharma.
Merck and Revolution Medicines are reportedly in talks for significant acquisitions, signaling rising M&A activity.
The conference remained busy with side events despite the lack of blockbuster announcements.